mitomycin has been researched along with mitoxantrone in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (18.06) | 18.7374 |
1990's | 36 (50.00) | 18.2507 |
2000's | 19 (26.39) | 29.6817 |
2010's | 4 (5.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrows, LR; Ireland, CM; Kokoshka, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bell, J; Blamey, RW; Dixon, AR; Ellis, IO; Elston, CW | 1 |
Adenis, A; Bonneterre, J; Degardin, M; Demaille, A; Hecquet, B; Pion, JM | 1 |
Barton, C; Bliss, JM; Bower, M; Coombes, RC; Ford, HT; Gazet, JC; Law, M; Stein, RC | 1 |
Astone, A; Barone, C; Cassano, A; Fontana, T; Noviello, MR; Pozzo, C | 1 |
Campora, E; Gardin, G; Giudici, S; Merlini, L; Miglietta, L; Naso, C; Pronzato, P; Queirolo, P; Repetto, L; Rosso, R | 1 |
Darling, JL; Hoffmann, O; Kraemer, HP; Nikkhah, G; Schachenmayr, W; Schönmayr, R; Tonn, JC | 1 |
Cold, S; Pfeiffer, P; Rose, C | 1 |
Crawford, ED; Thrasher, JB | 1 |
Chronides, A; Diedrich, K; Krebs, D; Mallmann, P; Wagner, U; Werner, A | 1 |
Ashley, SE; Hardy, JR; Jones, AL; Judson, IR; Powles, TJ | 1 |
Ashley, S; Jodrell, DI; Mansi, JL; McKinna, JA; Pearson, MC; Sinnett, HD; Smith, IE; Walsh, G | 1 |
Begin, L; Margolese, R; Panasci, L; Pollak, M; Reinke, A; Shenouda, G | 1 |
Bode, U; Diedrich, K; Krebs, D; Musch, E; Werner, A | 2 |
A'Hern, RP; Fisher, C; Harmer, CL; Mansi, JL; McKinna, JA; Sinnett, HD; Smith, IE; Trott, PA; Walsh, G | 1 |
Ashford, R; Dougherty, S; Goodman, A; Marks, A | 1 |
Iveson, TJ; Jodrell, DI; Smith, IE | 1 |
Anderson, H; Howell, A; Morton, AR | 1 |
Ashley, S; Powles, TI | 1 |
Belpomme, D; Cour, V; Gisselbrecht, C; Godeffroy, W; Le Rol, A; Maral, J; Marty, M; Mignot, L | 1 |
Davies, KJ; Doroshow, JH | 1 |
Blumenschein, GR; Buzdar, AU; Marcus, C; Smith, TL | 1 |
Blackledge, G; Chetiyawardana, AD; Hancock, A; Morrison, M; Mould, JJ; Perren, TJ | 1 |
Alberts, DS; Mason, N; Salmon, SE; Young, L | 1 |
Manyak, MJ | 1 |
Carmignani, G; Maffezzini, M; Raber, M; Simonato, A; Zanon, M | 1 |
Ali, HH; Lewis, WG; Sainsbury, JR; Walker, VA | 1 |
Bevan, DH; Gordon-Smith, EC; Philpott, NJ | 1 |
Bianco, AR; Carlomagno, C; De Laurentiis, M; De Placido, S; Del Mastro, L; Gravina, A; Gridelli, C; Pagliarulo, C; Perrone, F | 1 |
Ashley, SE; Luckit, J; Montes, A; O'Brien, ME; Powles, TJ; Treleaven, J | 1 |
Baum, M; Jones, AL; McKinna, JA; O'Brien, ME; Sacks, N; Smith, IE | 1 |
King, DM; Mansi, JL; Moskovic, EC; Murch, CR; Smith, IE | 1 |
Guy, RL; Husband, JE; Knee, G; MacVicar, AD; Powles, TJ; Sloane, JP; Vinnicombe, SJ | 1 |
Coombes, RC; Corbishley, C; Ford, HT; Gazet, JC; Griffin, M; Lowndes, S; Makinde, V; Quilliam, J; Sutcliffe, R | 1 |
Blomqvist, C; Jantunen, I; Kellokumpu-Lehtinen, P; Maiche, A; Muhonen, T; Pertovaara, H; Pyrhönen, S; Voutilainen, L | 1 |
George, WJ; Muchmore, JH; Preslan, JE | 1 |
Beger, HG; Leder, G; Link, KH; Pillasch, J; Weindel, M | 1 |
Ashley, S; Fernando, IN; Ford, HT; Grafton, D; Harmer, CL; Powles, TJ | 1 |
Hanada, R; Hongo, T; Horikoshi, Y; Sakurai, M; Yajima, S | 1 |
Ashley, S; Baum, M; Ebbs, S; Ellis, P; McKinna, J; Sacks, N; Smith, I; Walsh, G | 1 |
Ashley, S; Chang, JC; Gregory, RK; Powles, TJ | 1 |
Allred, DC; Ashley, SE; Dowsett, M; Fernando, IN; Gregory, RK; Makris, A; Ormerod, MG; Osborne, CK; Powles, TJ; Titley, JC; Trott, PA | 1 |
Beger, HG; Butzer, U; Gansauge, F; Kornmann, M; Leder, GH; Link, KH; Pillasch, J; Staib, L | 1 |
Beger, HG; Kornmann, M; Leder, G; Link, KH; Pillasch, AF; Pressmar, J; Schatz, M; Sunelaitis, E | 1 |
Lowdell, CP; Partridge, SE | 1 |
Moiseenko, VM; Orlova, RV | 1 |
Melekos, MD; Moutzouris, GD | 1 |
Danenberg, PV; Kornmann, M; Leder, GH; Link, KH; Pillasch, J | 1 |
Ansaloni, L; Bazzocchi, R; Bini, A; Grazia, M; Stella, F; Zompatori, M | 1 |
Ashley, S; Kuan, A; Kulkarni, S; Mehta, J; Mitchell, P; Powles, R; Powles, T; Saso, R; Swansbury, GJ; Treleaven, J | 1 |
Beger, HG; Butzer, U; Danenberg, KD; Danenberg, PV; Kornmann, M; Leder, G; Link, KH; Pillasch, J; Salonga, D; Sunelaitis, E | 1 |
Deo, SV; Goel, A; Mohanty, BK; Raina, V; Rath, GK; Sharma, A; Shukla, NK | 1 |
Guaraldi, M; Marino, A; Martoni, A; Melotti, B; Pannuti, F; Piana, E; Pinto, C | 1 |
Coombes, RC; Ford, HT; Gazet, JC; Gray, R; Lowndes, S; Makinde, V; McConkey, C; Quilliam, J; Sutcliffe, R | 1 |
Blamey, RW; Chan, SY; Cheung, KL; Robertson, JF; Tan, SM; Willsher, PC | 1 |
Beger, HG; Formentini, A; Gansauge, F; Kornmann, M; Leder, G; Link, KH; Pillasch, J; Schatz, M; Staib, L; Sunelaitis, E | 1 |
Holguin, MH; Morgan, CD | 1 |
Ernst, H; Fahrig, R; Fiedler, B; Heinrich, JC; Krupitza, G; Leisser, C; Nickel, B; Praha, C; Scherthan, H; Sonntag, D; Wilfert, F | 1 |
Ashizawa, T; Hashem, VI; Khajav, M; Khajavi, M; Klysik, EA; Pytlos, MJ; Sinden, RR; Tsuji, K | 1 |
Dahlke, MH; Klempnauer, J; Piso, P; Schlitt, HJ; Schmidt, U | 1 |
Benedetti, G; De Pangher Manzini, V; Del Conte, G; dell'Amore, D; Galetta, D; Giaquinta, S; Lopez, M; Marino, A; Martoni, A; Mazzanti, P; Piana, E; Pinto, C | 1 |
Agrawal, A; Asgeirsson, KS; Chan, SY; Cheung, KL; Ellis, IO; Mathew, J; Mukherjee, A; Robertson, JF | 1 |
Hiraoka, M; Imagunbai, T; Inoue, T; Mitsumori, M; Negoro, Y; Sai, H; Sasaki, S; Sasaki, Y; Shikama, N; Takegawa, H; Teshima, T; Yamauchi, C | 1 |
Kulcsár, G | 1 |
Halverson, AL; Hogg, ME; Kiel, KD; Popowich, DA; Stryker, SJ; Wang, EC | 1 |
Kepp, O; Kroemer, G; Martins, I; Métivier, D; Michaud, M; Perfettini, JL; Schlemmer, F; Senovilla, L; Séror, C; Tesniere, A; Zitvogel, L | 1 |
Hirano, S; Kuroda, A; Kuwatani, T; Kyogoku, N; Maki, T; Miyauchi, K; Shichinohe, T; Takeuchi, S; Tsuchikawa, T; Wada, M; Yamamura, Y | 1 |
8 review(s) available for mitomycin and mitoxantrone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[A study of VMMC protocol (vindesine, mitoxantrone, mitomycin C) as a salvage chemotherapy in advanced breast cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Prognosis; Salvage Therapy; Vindesine | 1992 |
Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use?
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Vincristine | 1992 |
Complications of intravesical chemotherapy.
Topics: Administration, Intravesical; Antineoplastic Agents; Carcinoma, Transitional Cell; Doxorubicin; Epirubicin; Ethoglucid; Humans; Mitomycin; Mitoxantrone; Thiotepa; Urinary Bladder Neoplasms | 1992 |
Mitoxantrone, 5-FU + folinic acid, mitomycin C for regional chemotherapy of malignant liver tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Regional Perfusion; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Mitomycin; Mitoxantrone | 1996 |
Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colorectal Neoplasms; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitoxantrone; Randomized Controlled Trials as Topic; Survival Analysis | 1999 |
Intravesical therapy of superficial bladder cancer.
Topics: Administration, Intravesical; Antineoplastic Agents; Doxorubicin; Epirubicin; Humans; Immunotherapy; Interferons; Mitomycin; Mitoxantrone; Mycobacterium bovis; Thiotepa; Urinary Bladder Neoplasms | 2000 |
Bilateral recurrent pneumothorax complicating chemotherapy for pulmonary metastatic breast ductal carcinoma: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Drainage; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Pneumothorax; Recurrence; Treatment Outcome | 2000 |
25 trial(s) available for mitomycin and mitoxantrone
Article | Year |
---|---|
[A study of VMMC protocol (vindesine, mitoxantrone, mitomycin C) as a salvage chemotherapy in advanced breast cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Prognosis; Salvage Therapy; Vindesine | 1992 |
Mitozantrone and methotrexate chemotherapy with and without mitomycin C in the treatment of advanced breast cancer: a randomised clinical trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neutropenia | 1992 |
Salvage chemotherapy with mitoxantrone and mitomycin with or without methotrexate in advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Salvage Therapy | 1992 |
A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone; Vincristine | 1991 |
A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone; Neoplasm Staging | 1991 |
Mitomycin C and mitoxantrone chemotherapy for advanced breast cancer: efficacy with minimal gastrointestinal toxicity and alopecia.
Topics: Alkylating Agents; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Digestive System; Female; Humans; Mitomycin; Mitomycins; Mitoxantrone; Remission Induction; Time Factors | 1990 |
Myelosuppression after methotrexate, mitoxantrone, and mitomycin C.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Methotrexate; Mitomycin; Mitomycins; Mitoxantrone; Random Allocation | 1987 |
Intra-arterial chemotherapy in patients with breast cancer: a feasibility study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Staging | 1995 |
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Remission Induction; Salvage Therapy; Survival Analysis | 1994 |
A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Interactions; Female; Hemolytic-Uremic Syndrome; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Retrospective Studies; Tamoxifen; Thrombocytopenia | 1993 |
Primary medical (neo-adjuvant) chemotherapy for operable breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone | 1993 |
Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Female; Humans; Mammography; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Tamoxifen | 1996 |
Prophylactic filgrastim (G-CSF) during mitomycin-C, mitoxantrone, and methotrexate (MMM) treatment for metastatic breast cancer. A randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Recombinant Proteins | 1996 |
Regional chemotherapy for inoperable pancreatic carcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mitomycin; Mitoxantrone; Pancreatic Neoplasms; Treatment Outcome | 1996 |
An acute toxicity study on the effects of synchronous chemotherapy and radiotherapy in early stage breast cancer after conservative surgery.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Multivariate Analysis; Radiation Injuries; Radiation Pneumonitis; Random Allocation; Skin | 1996 |
A randomised trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Hematologic Diseases; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Palliative Care; Prospective Studies; Survival Rate; Vincristine | 1997 |
Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Female; Humans; Menopause; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Staging; Ploidies; Predictive Value of Tests; Proto-Oncogene Proteins c-bcl-2; Receptors, Estrogen; Receptors, Progesterone; S Phase; Tamoxifen | 1997 |
Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision-aiding trial.
Topics: Adult; Aged; Antidotes; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitoxantrone; Neoplastic Stem Cells; Prospective Studies; Tumor Stem Cell Assay | 1996 |
Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Folic Acid; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitoxantrone; Predictive Value of Tests; Prospective Studies; Thymidylate Synthase; Treatment Outcome; Tumor Stem Cell Assay | 2000 |
Combination chemotherapy with mitoxantrone, methotrexate, and mitomycin (MMM regimen) in malignant pleural mesothelioma: a phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Mesothelioma; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Pleural Neoplasms; Survival Analysis | 2001 |
Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy.
Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Goserelin; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoadjuvant Therapy; Neoplasm Metastasis; Postmenopause; Premenopause; Prognosis; Receptors, Estrogen; Survival Analysis | 2001 |
Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Mastectomy; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Postoperative Care; Prospective Studies; Receptors, Estrogen; Survival Analysis; Treatment Outcome | 2001 |
Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitoxantrone; Survival Analysis; Treatment Outcome | 2001 |
Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Female; Follow-Up Studies; Gemcitabine; Humans; Italy; Male; Mesothelioma; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Staging; Pleural Neoplasms; Retrospective Studies; Treatment Outcome | 2006 |
Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Survival Rate; Treatment Outcome; United Kingdom | 2007 |
40 other study(ies) available for mitomycin and mitoxantrone
Article | Year |
---|---|
Cell-based screen for identification of inhibitors of tubulin polymerization.
Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured | 1996 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Resistance; Female; Humans; Membrane Glycoproteins; Methotrexate; Mitomycin; Mitoxantrone; Neoplasm Proteins; Neoplasm Staging | 1992 |
Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Mitomycin; Mitoxantrone | 1992 |
The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Cell Survival; Colony-Forming Units Assay; Coloring Agents; Drug Screening Assays, Antitumor; Glioma; Humans; Mitomycin; Mitoxantrone; Nimustine; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1992 |
[Locoregional ascites therapy with cytostatic drugs and immune modulators in gynecologic neoplasms].
Topics: Ascites; Breast Neoplasms; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Interferon-beta; Mitomycin; Mitoxantrone; Ovarian Neoplasms; Peritoneal Neoplasms; Tumor Necrosis Factor-alpha; Uterine Neoplasms | 1991 |
Intraoperative, intraperitoneal chemotherapy in advanced gynecological malignancies. A report on the acceptability of a new therapeutic regimen.
Topics: Combined Modality Therapy; Female; Genital Neoplasms, Female; Humans; Intraoperative Care; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone | 1989 |
Primary medical therapy for operable breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Gonadotropin-Releasing Hormone; Hormones; Humans; Leuprolide; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone; Tamoxifen | 1989 |
Myelosuppression after methotrexate, mitozantrone, and mitomycin C for treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone | 1987 |
Myelotoxicity of methotrexate, mitozantrone, and mitomycin C.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone | 1987 |
Myelosuppression after methotrexate, mitozantrone, and mitomycin C combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Humans; Methotrexate; Mitomycin; Mitomycins; Mitoxantrone | 1987 |
[Prolonged remissions induced by the combination vindesine, mitoxantrone, mitomycine C in metastatic breast cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone; Neoplasm Metastasis; Time Factors; Vindesine | 1987 |
Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical.
Topics: Animals; Anthraquinones; Antibiotics, Antineoplastic; Cattle; Chemical Phenomena; Chemistry; Daunorubicin; Doxorubicin; Electron Spin Resonance Spectroscopy; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Methane; Mitochondria, Heart; Mitomycin; Mitomycins; Mitoxantrone; NAD; NADP; Naphthacenes; Oxidation-Reduction; Oxygen Consumption; Rotenone; Superoxides | 1986 |
Twenty-first Paterson symposium: bioactivation of quinone anti-tumor agents.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Aziridines; Benzoquinones; Biotransformation; DNA Damage; Free Radicals; Mitomycin; Mitomycins; Mitoxantrone; Naphthacenes; Quinones | 1987 |
[Tolerance of intraoperative, intraperitoneal chemotherapy in advanced gynecologic malignancies].
Topics: Adolescent; Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Lavage; Reoperation; Uterine Neoplasms | 1988 |
Early and delayed clinical cardiotoxicity of doxorubicin.
Topics: Adult; Aged; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Fluorouracil; Follow-Up Studies; Heart Diseases; Heart Failure; Humans; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone; Neoplasm Recurrence, Local; Risk; Time Factors | 1985 |
Phase II study of vincristine, mitomycin-C and mitoxantrone in advanced breast cancer: a preliminary report of response and toxicity.
Topics: Adolescent; Adult; Aged; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Hemoglobins; Humans; Leukopenia; Menopause; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone; Sleep Stages; Vincristine | 1985 |
In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administration.
Topics: Anthraquinones; Antineoplastic Agents; Cisplatin; Colony-Forming Units Assay; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Parenteral; Melphalan; Mitomycin; Mitomycins; Mitoxantrone; Ovarian Neoplasms; Peritoneal Cavity; Tumor Stem Cell Assay | 1985 |
Bladder carcinoma--the good, the bad and the ugly.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Doxorubicin; Humans; Mitomycin; Mitoxantrone; Palliative Care; Radiotherapy, High-Energy; Urinary Bladder Neoplasms | 1996 |
Up-front intravesical chemotherapy for low stage, low grade recurrent bladder cancer.
Topics: Administration, Intravesical; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Mitomycin; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm, Residual; Prospective Studies; Time Factors; Urinary Bladder Neoplasms | 1996 |
Secondary leukaemia after MMM combined modality therapy for breast carcinoma.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Female; Humans; Leukemia, Myeloid; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasms, Second Primary | 1993 |
Mammography in the assessment of response to medical treatment of large primary breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Calcinosis; Cyclophosphamide; Female; Fluorouracil; Humans; Mammography; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Tamoxifen | 1993 |
Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer.
Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Goserelin; Humans; Immunohistochemistry; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasms, Hormone-Dependent; Receptors, Estrogen | 1996 |
In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
Topics: Aclarubicin; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow; Cell Survival; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Life Tables; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Recurrence; Remission Induction; Tumor Cells, Cultured; Vincristine | 1997 |
Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Cisplatin; Disease Progression; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Treatment Outcome | 1998 |
Myelodysplastic syndrome as a complication of neo-adjuvant triple M chemotherapy and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Myelodysplastic Syndromes; Neoadjuvant Therapy; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy | 1999 |
[Effectiveness of current chemotherapy in metastatic breast cancer resistant to anthracycline antibiotics].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Staging; Paclitaxel; Retrospective Studies; Treatment Outcome; Vinblastine; Vinorelbine | 1999 |
Theoretical considerations and in vitro concentration response studies with two human colorectal carcinoma cell lines. The rational experimental base for clinical studies in regional chemotherapy.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carcinoma; Cisplatin; Colorectal Neoplasms; Doxorubicin; Epirubicin; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Melphalan; Mitomycin; Mitoxantrone; Tumor Cells, Cultured | 2000 |
Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma.
Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; England; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Incidence; Leukemia, Myeloid; Leukemia, Radiation-Induced; Life Tables; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prospective Studies; Registries; Risk; Survival Analysis; Tamoxifen; Translocation, Genetic | 2000 |
Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; India; Mastectomy, Modified Radical; Mastectomy, Radical; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Staging; Radiotherapy, Adjuvant; Treatment Outcome | 1998 |
Chemotherapeutic stress mediated by certain antitumor antibiotics induces an atypical CD69+ surface phenotype in peripheral T-lymphocytes.
Topics: Antibiotics, Antineoplastic; Antibodies, Blocking; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Bleomycin; Dactinomycin; Dose-Response Relationship, Drug; Humans; Immunophenotyping; Lectins, C-Type; Mannitol; Mitomycin; Mitoxantrone; Plicamycin; Spectrometry, Fluorescence; Stress, Physiological; T-Lymphocytes; Thymidine | 2002 |
Inhibition of induced chemoresistance by cotreatment with (E)-5-(2-bromovinyl)-2'-deoxyuridine (RP101).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cisplatin; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Electrophoresis, Gel, Two-Dimensional; Fibroblasts; Ifosfamide; Methotrexate; Mice; Mitomycin; Mitoxantrone; NAD(P)H Dehydrogenase (Quinone); Rats; Rats, Sprague-Dawley; Sarcoma, Yoshida; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; STAT3 Transcription Factor; Trans-Activators; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2003 |
Chemotherapeutic deletion of CTG repeats in lymphoblast cells from DM1 patients.
Topics: Alleles; Antineoplastic Agents, Alkylating; Cell Line; Doxorubicin; Ethyl Methanesulfonate; Humans; Lymphocytes; Mitomycin; Mitoxantrone; Myotonic Dystrophy; Trinucleotide Repeat Expansion | 2004 |
Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Female; Health Status; Humans; Male; Middle Aged; Mitomycin; Mitoxantrone; Peritoneal Neoplasms; Postoperative Complications; Prognosis; Quality of Life; Surveys and Questionnaires | 2005 |
Patterns of care study of breast-conserving therapy in Japan: comparison of the treatment process between 1995 1997 and 1999 2001 surveys.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Japan; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Staging; Paclitaxel; Population Surveillance; Practice Patterns, Physicians'; Radiotherapy, Adjuvant; Tamoxifen; Vinblastine; Vincristine | 2007 |
Experimental evidence for killing the resistant cells and raising the efficacy and decreasing the toxicity of cytostatics and irradiation by mixtures of the agents of the passive antitumor defense system in the case of various tumor and normal cell lines
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Male; Mitomycin; Mitoxantrone; Neoplasms; Prostatic Neoplasms; Rats; Recurrence; Vinblastine | 2009 |
HIV and anal cancer outcomes: a single institution's experience.
Topics: Antineoplastic Agents; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Colostomy; Deoxycytidine; Female; Fluorouracil; HIV Infections; Humans; Male; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies | 2009 |
Chemotherapy induces ATP release from tumor cells.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Cadmium; Cell Line, Tumor; Cisplatin; Etoposide; Flow Cytometry; Fluorescent Antibody Technique; Mice; Mitomycin; Mitoxantrone; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Sphingosine; Thapsigargin | 2009 |
The key role of calreticulin in immunomodulation induced by chemotherapeutic agents.
Topics: Animals; Antigens, Surface; Antineoplastic Agents; Apoptosis; Calreticulin; Camptothecin; Carcinoma, Lewis Lung; CD3 Complex; Cell Line, Tumor; Cell Survival; Cisplatin; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Histocompatibility Antigens Class I; Humans; Immunomodulation; Lymphocyte Count; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitomycin; Mitoxantrone; Neoplasm Transplantation; Neoplasms, Experimental; Protein Transport; T-Lymphocytes; Tumor Microenvironment | 2015 |